Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2009

01-10-2009 | Article

The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East

Authors: M. Sugimoto, M. R. Zali, Y. Yamaoka

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2009

Login to get access

Abstract

The variations in the three regions of the Helicobacter pylori vacA gene, the signal (s1 and s2), intermediate (i1 and i2) and middle regions (m1 and m2), are known to cause the differences in vacuolating activities. However, it was unclear whether these vacA genotypes are associated with the development of gastric cancer and peptic ulcer in the Middle East. The aim was to identify the prevalence of vacA genotypes in the Middle East and the association with gastroduodenal diseases. We investigated the relationship of vacA genotypes to H. pylori-related disease development by meta-analysis using previous reports of 1,646 patients from the Middle East. The frequency of the vacA s1, m1 and i1 genotypes in the Middle Eastern strains was 71.5% (1,007/1,409), 32.8% (427/1,300) and 40.7% (59/145), respectively. Importantly, the frequency of vacA s- and m-region genotypes significantly differed between the north and south parts of the Middle East countries (P < 0.001). The vacA genotypes significantly increased the risk of gastric cancer (odds ratio [OR]: 4.02, 95% confidence interval [CI]: 1.98–8.14 for the s1 genotype; 2.50, 1.62–3.85 for m1; 5.27, 1.97–14.1 for s1m1; 15.03, 4.69–48.17 for i1) and peptic ulcers (OR: 3.07, 95% CI: 2.08–4.52 for s1; 1.81, 1.36–2.42 for m1). The cagA-positive genotype frequently coincided with the s1, m1 and i1 genotypes. The vacA s- and m-region genotypes may be useful risk factors for gastrointestinal diseases in the Middle East, similar to European and American countries. Further studies will be required to evaluate the effects of the i-region genotype.
Literature
1.
go back to reference Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE et al (1990) Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 161(6):1237–1241PubMed Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE et al (1990) Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 161(6):1237–1241PubMed
2.
go back to reference Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT et al (1992) Indirect immunofluorescence determination of the frequency of anti-H. pylori antibodies in Brazilian blood donors. Braz J Med Biol Res 25(7):683–689PubMed Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT et al (1992) Indirect immunofluorescence determination of the frequency of anti-H. pylori antibodies in Brazilian blood donors. Braz J Med Biol Res 25(7):683–689PubMed
3.
go back to reference Souto FJ, Fontes CJ, Rocha GA, de Oliveira AM, Mendes EN, Queiroz DM (1998) Prevalence of Helicobacter pylori infection in a rural area of the state of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 93(2):171–174PubMed Souto FJ, Fontes CJ, Rocha GA, de Oliveira AM, Mendes EN, Queiroz DM (1998) Prevalence of Helicobacter pylori infection in a rural area of the state of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 93(2):171–174PubMed
4.
go back to reference Sandikci MU, Doran F, Koksal F, Sandikci S, Uluhan R, Varinli S et al (1993) Helicobacter pylori prevalence in a routine upper gastrointestinal endoscopy population. Br J Clin Pract 47(4):187–189PubMed Sandikci MU, Doran F, Koksal F, Sandikci S, Uluhan R, Varinli S et al (1993) Helicobacter pylori prevalence in a routine upper gastrointestinal endoscopy population. Br J Clin Pract 47(4):187–189PubMed
5.
go back to reference Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 7(5):427–433PubMed Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 7(5):427–433PubMed
6.
9.
go back to reference Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372(9636):392–397. doi:10.1016/S0140-6736(08)61159-9 PubMedCrossRef Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372(9636):392–397. doi:10.​1016/​S0140-6736(08)61159-9 PubMedCrossRef
10.
go back to reference Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270(30):17771–17777. doi:10.1074/jbc.270.30.17771 PubMedCrossRef Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270(30):17771–17777. doi:10.​1074/​jbc.​270.​30.​17771 PubMedCrossRef
13.
go back to reference Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M et al (2007) A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3):926–936. doi:10.1053/j.gastro.2007.06.056 PubMedCrossRef Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M et al (2007) A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3):926–936. doi:10.​1053/​j.​gastro.​2007.​06.​056 PubMedCrossRef
15.
go back to reference Kidd M, Lastovica AJ, Atherton JC, Louw JA (1999) Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut 45(4):499–502PubMedCrossRef Kidd M, Lastovica AJ, Atherton JC, Louw JA (1999) Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut 45(4):499–502PubMedCrossRef
17.
go back to reference Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P et al (2001) Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 36(2):128–135. doi:10.1080/00365520120921 PubMedCrossRef Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P et al (2001) Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 36(2):128–135. doi:10.​1080/​00365520120921 PubMedCrossRef
18.
19.
go back to reference Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY (1999) Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37(7):2274–2279PubMed Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY (1999) Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37(7):2274–2279PubMed
23.
24.
25.
go back to reference Caner V, Yilmaz M, Yonetci N, Zencir S, Karagenc N, Kaleli I et al (2007) H pylori iceA alleles are disease-specific virulence factors. World J Gastroenterol 13(18):2581–2585PubMed Caner V, Yilmaz M, Yonetci N, Zencir S, Karagenc N, Kaleli I et al (2007) H pylori iceA alleles are disease-specific virulence factors. World J Gastroenterol 13(18):2581–2585PubMed
27.
go back to reference Umit H, Tezel A, Bukavaz S, Unsal G, Otkun M, Soylu AR et al (2009) The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients. Dig Dis Sci 54:103–110PubMedCrossRef Umit H, Tezel A, Bukavaz S, Unsal G, Otkun M, Soylu AR et al (2009) The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients. Dig Dis Sci 54:103–110PubMedCrossRef
29.
go back to reference Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M et al (2003) Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bull Soc Pathol Exot 96(1):3–5PubMed Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M et al (2003) Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bull Soc Pathol Exot 96(1):3–5PubMed
31.
go back to reference Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M (2006) Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 12(32):5205–5210PubMed Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M (2006) Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 12(32):5205–5210PubMed
32.
go back to reference Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H et al (2008) vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 61(4):290–293PubMed Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H et al (2008) vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 61(4):290–293PubMed
33.
go back to reference Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK et al (2008) Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 46(5):1774–1779. doi:10.1128/JCM.01737-07 PubMedCrossRef Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK et al (2008) Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 46(5):1774–1779. doi:10.​1128/​JCM.​01737-07 PubMedCrossRef
34.
go back to reference Momenah AM, Tayeb MT (2006) Relationship between Helicobacter pylori vacA genotypes status and risk of peptic ulcer in Saudi patients. Saudi Med J 27(6):804–807PubMed Momenah AM, Tayeb MT (2006) Relationship between Helicobacter pylori vacA genotypes status and risk of peptic ulcer in Saudi patients. Saudi Med J 27(6):804–807PubMed
37.
go back to reference Sugimoto M, Yamaoka Y (2009) The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect (in press) Sugimoto M, Yamaoka Y (2009) The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect (in press)
38.
go back to reference Farshad S, Japoni A, Alborzi A, Hosseini M (2007) Restriction fragment length polymorphism of virulence genes cagA, vacA and ureAB of Helicobacter pylori strains isolated from Iranian patients with gastric ulcer and nonulcer disease. Saudi Med J 28(4):529–534PubMed Farshad S, Japoni A, Alborzi A, Hosseini M (2007) Restriction fragment length polymorphism of virulence genes cagA, vacA and ureAB of Helicobacter pylori strains isolated from Iranian patients with gastric ulcer and nonulcer disease. Saudi Med J 28(4):529–534PubMed
39.
go back to reference Bulent K, Murat A, Esin A, Fatih K, MMMurat H, Hakan H et al (2003) Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol 9(7):1580–1583PubMed Bulent K, Murat A, Esin A, Fatih K, MMMurat H, Hakan H et al (2003) Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol 9(7):1580–1583PubMed
43.
go back to reference Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P et al (2001) Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 158(2):647–654PubMed Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P et al (2001) Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 158(2):647–654PubMed
44.
go back to reference Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpção MB, Vilar SC et al (2005) Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz 100(8):875–881. doi:10.1590/S0074-02762005000800009 PubMedCrossRef Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpção MB, Vilar SC et al (2005) Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz 100(8):875–881. doi:10.​1590/​S0074-0276200500080000​9 PubMedCrossRef
45.
go back to reference van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WG (1999) Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol 37(7):2306–2311PubMed van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WG (1999) Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol 37(7):2306–2311PubMed
46.
go back to reference Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR (1998) Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36(8):2258–2263PubMed Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR (1998) Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36(8):2258–2263PubMed
47.
go back to reference Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK, Rajendran K et al (2002) Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol 40(7):2622–2625. doi:10.1128/JCM.40.7.2622-2625.2002 PubMedCrossRef Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK, Rajendran K et al (2002) Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol 40(7):2622–2625. doi:10.​1128/​JCM.​40.​7.​2622-2625.​2002 PubMedCrossRef
50.
go back to reference Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M et al (2003) Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 107(1):113–118. doi:10.1002/ijc.11359 PubMedCrossRef Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M et al (2003) Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 107(1):113–118. doi:10.​1002/​ijc.​11359 PubMedCrossRef
51.
go back to reference Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM (2005) Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 6(3):359–363PubMed Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM (2005) Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 6(3):359–363PubMed
Metadata
Title
The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East
Authors
M. Sugimoto
M. R. Zali
Y. Yamaoka
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0772-y

Other articles of this Issue 10/2009

European Journal of Clinical Microbiology & Infectious Diseases 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.